Myomo Inc (MYO)
Official siteHEALTHCARE • MEDICAL DEVICES • AMEX
Market Cap: $49.32M
Last updated: Nov 17, 2026 at 4:10 PM ET
Myomo Inc (MYO) Statistics
Myomo (MYO) has a market cap of $49.32M and an enterprise value of $58.79M. It kept -33.14% of revenue as net income over the last 12 months. Its share count is up 3.33% from a year earlier.
Total Valuation
Enterprise value is 19.21% above the market cap, as debt exceeds cash.
| Market Cap | $49.32M |
|---|---|
| Enterprise Value | $58.79M |
| Latest price (Nov 17, 2026) | $0.92 |
Key Dates
The next earnings report is set for Mar 8, 2027, after the close.
| Next Earnings Date | Mar 8, 2027, after the close |
|---|---|
| Last Earnings Date | Nov 9, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 0.9x and 14.6x. Its year-end P/S ranged from 0.2x to 25.2x from 2018 to 2025.
| P/S Ratio | 0.9x |
|---|---|
| Forward P/S | 1.1x |
| P/B Ratio | 14.6x |
| P/TBV Ratio | 36.5x |
Price Statistics
The stock is up 12.78% over 52 weeks and trades 31.85% below its 50-day average.
| Beta (1Y) | 2.32 |
|---|---|
| 52-Week Change | +12.78% |
| 1-Month Change | -26.38% |
| 3-Month Change | -50.53% |
| 6-Month Change | +4.78% |
| 5-Year Change | -87.76% |
| Total Return (1Y) | +12.78% |
| Total Return (3Y CAGR) | -31.71% |
| Total Return (5Y CAGR) | -36.54% |
| Max Drawdown (1Y) | -50.53% |
| Max Drawdown (3Y) | -90.84% |
| Sharpe Ratio (1Y) | 0.25 |
| Correlation with SPY (1Y) | 0.33 |
| 50-Day Average | $1.35 |
| 200-Day Average | $1.10 |
| 52-Week Range | $0.60 to $1.89 |
| RSI (14 Days) | 32.2 |
| Average Volume (20 Days) | 263.88K |
The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 1.92x current liabilities, and total debt is 7.48x shareholder equity.
| Current Ratio | 1.92x |
|---|---|
| Quick Ratio | 1.66x |
| Debt / Equity | 7.48x |
Returns and Efficiency
Return on invested capital is -51.95% over the last 12 months, against a 5-year average of -63.65%.
| Return on Equity (ROE) | -548.13% |
|---|---|
| Return on Assets (ROA) | -44.60% |
| Return on Invested Capital (ROIC) | -51.95% |
| Return on Capital Employed (ROCE) | -56.26% |
| ROA (5Y Average) | -67.38% |
| ROIC (5Y Average) | -63.65% |
| Asset Turnover | 1.34x |
| Inventory Turnover | 4.34x |
| Receivables Turnover | 8.37x |
| Cash Conversion Cycle | -65 days |
Scores
MYO has an Altman Z-Score of -4.05, in the distress zone below 1.81, and a Piotroski F-Score of 3 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | -4.05 |
|---|---|
| Altman Z Zone | Distress |
| Piotroski F-Score | 3 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue of $45.50M over the last 12 months is up 9.27% from the 12 months before.
| Revenue | $45.50M |
|---|---|
| Revenue Growth (YoY) | +9.27% |
| Gross Profit | $31.92M |
| Operating Income | -$9.91M |
| Pretax Income | -$14.67M |
| Net Income | -$15.08M |
| EBITDA | -$8.71M |
| EBIT | -$12.12M |
| Reported EPS (TTM) | -$0.32 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 8.14% of the $33.80M in total assets.
| Cash and Equivalents | $11.10M |
|---|---|
| Total Debt | $20.57M |
| Net Debt | $9.47M |
| Net Debt Per Share | $0.22 |
| Working Capital | $11.23M |
| Shareholder Equity | $2.75M |
| Book Value Per Share | $0.06 |
| Tangible Book Value | $1.10M |
| Tangible Book Per Share | $0.03 |
| Total Assets | $33.80M |
| Total Liabilities | $31.05M |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $1.00M of capital spending, operating cash flow left -$7.59M of free cash flow.
| Operating Cash Flow | -$6.59M |
|---|---|
| Capital Expenditures | $1.00M |
| Free Cash Flow | -$7.59M |
| FCF Per Share | -$0.19 |
| Depreciation and Amortization | $3.41M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is -21.78%.
| Gross Margin | 70.15% |
|---|---|
| Operating Margin | -21.78% |
| Pretax Margin | -32.24% |
| Net Margin | -33.14% |
| EBITDA Margin | -19.13% |
| EBIT Margin | -26.63% |
| FCF Margin | -16.69% |
Growth
Revenue grew 38.05% a year over 3 years.
| Revenue Growth (3Y CAGR) | +38.05% |
|---|---|
| Revenue Growth (5Y CAGR) | +40.10% |
| Book Value Per Share Growth (2Y CAGR) | +3.26% |
| Tangible Book Per Share Growth (2Y CAGR) | -4.21% |
Dividends and Yields
MYO does not pay a dividend. Its free cash flow yield is -18.94%.
| FCF Yield | -18.94% |
|---|---|
| Buyback Yield | 0.32% |
| Shareholder Yield | 0.32% |
Stock Splits
The last split was a 1-for-30 reverse split on Jan 31, 2020.
| Last Split Date | Jan 31, 2020 |
|---|---|
| Split Type | Reverse split |
| Split Ratio | 1:30 |
Peer Position
Against 11 similar companies, MYO has the 8th highest P/S.
P/S RatioPeer median 2.2x
ROICPeer median -58.94%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +17.04%
| P/S Ratio | 0.9x vs 2.2x median |
|---|---|
| ROIC | -51.95% vs -58.94% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +9.27% vs +17.04% median |
Analyst Forecast
Consensus estimates put revenue growth at 11.73% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +11.73% |
|---|
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Overvalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About MYO
What is MYO's market cap?
Myomo has a market cap of $49.32M. Its enterprise value, which adds debt and subtracts cash, is $58.79M.
How many shares of MYO are outstanding?
Myomo has 43.57M shares outstanding. The count is up 3.33% from a year earlier.
Does MYO pay a dividend?
No. Myomo does not pay a dividend.
How much debt does MYO have?
Myomo has $20.57M of total debt and $11.10M of cash and equivalents, a net debt position of $9.47M.
MYO pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors, Government Contracts